Daiwa Securities Group Inc. Chemo Centryx, Inc. Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	BUY	$15.36 - $27.51 $936 - $1,678	61 Added 29.9%	265 $7,000
Q4 2021 Feb 03, 2022	SELL	$18.38 - $40.5 $643 - $1,417	-35 Reduced 14.64%	204 $7,000
Q3 2021 Nov 05, 2021	BUY	$13.18 - $19.83 $1,344 - $2,022	102 Added 74.45%	239 $4,000
Q1 2021 May 03, 2021	BUY	$49.53 - $68.4 $346 - $478	7 Added 5.38%	137 $7,000
Q4 2020 Feb 04, 2021	SELL	$47.25 - $65.16 $12,237 - $16,876	-259 Reduced 66.58%	130 $8,000
Q3 2020 Nov 02, 2020	BUY	$46.35 - $61.69 $2,781 - $3,701	60 Added 18.24%	389 $21,000
Q4 2019 Jan 31, 2020	SELL	$6.81 - $39.55 $245 - $1,423	-36 Reduced 9.86%	329 $13,000
Q2 2019 Jul 24, 2019	BUY	$8.31 - $14.85 $797 - $1,425	96 Added 35.69%	365 $3,000
Q1 2018 May 02, 2018	BUY	$5.9 - $14.99 $1,587 - $4,032	269 New	269 $4,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.